WHO shows interest in Guj's SMS model to check fake medicines
The World Health Organisation has shown interest in Gujarat's SMS alert system of keeping a check on spurious medicines, a top health official said.
Ahmedabad: The World Health Organisation has shown interest in Gujarat's SMS alert system of keeping a check on spurious medicines, a top health official said.
As part of its e-governance initiative, the Gujarat Food and Drug Control Administration (FDCA) had developed an SMS alert system through which all the stakeholders in the state could be notified of the recalled fake drugs.
This cost-effective model was launched in the state earlier this year to protect the patients from spurious drugs.
"WHO has evinced interest in Gujarat's SMS recall model for the spurious drugs. It plans to implement this cost-effective model for patient safety in the developing countries," Gujarat FDCA Commissioner H G Koshia said.
"We have submitted a concept note of this model to them, after the recent visit of Dr Veer Surya from WHO headquarters to Gujarat's FDCA," he said.
Commenting on the model, Dr Surya had said that it was a viable tool to protect the patients' health and could be implemented in the developing countries, Koshia said.
This model has also been appreciated and praised by top executives of global pharma giants like US-based Abott Laboratories and Israel-based Teva Pharmaceutical.
WHO is the directing and coordinating authority for health within the United Nation system, with over 150 countries as its members.
Several Indian states are also in the process of replicating this model.
The system has issued around 60 alerts so far on sub-standards drugs detected during random sampling done by the FDCA, asking chemists to stop the sale of such spurious medicine.
Bombay HC asks Maharashtra govt to scrutinise Sonu Sood, Cong MLA Zeeshan Siddique's role in procuring anti-COVID drugs
The Bombay High Court also noted that "these people (celebrities) projected themselves as some kind of messiahs without verifying if the drugs were spurious or if the supply was legal."
Switzerland's Bejart Ballet Lausanne company faces probe over allegations of drug abuse and harassment
Swiss public broadcaster RTS reported that a number of unidentified former members of the Bejart Ballet Lausanne (BBL) company had written to the foundation, describing the "omnipresence of drugs, nepotism, as well as psychological and sexual harassment".
Biogen said the drug would cost approximately $56,000 for a typical year’s worth of treatment, adding that the price would not be raised for four years